What is the recommended treatment for CMV retinitis in an AIDS patient?
Which of the following mechanisms is mainly responsible for gentamicin-induced ototoxicity?
Which of the following drugs is NOT used in the treatment of Leishmaniasis?
Which of the following drugs can cause cartilage damage in children?
What is the recommended single dose of fosfomycin for a 40-year-old patient weighing 60 kg?
All of the following are true about Penicillins except?
Terbinafine hydrochloride is:
Which of the following antifungal agents is used in the treatment of Cushing's syndrome?
Palivizumab is a humanized monoclonal antibody. For which of the following conditions has it been approved for?
Which of the following is a beta-lactamase resistant penicillin?
Explanation: **Explanation:** **Cytomegalovirus (CMV) retinitis** is the most common opportunistic ocular infection in patients with AIDS (typically when CD4 counts fall below 50 cells/mm³). **Why Valganciclovir is correct:** Valganciclovir is the **L-valyl ester prodrug of Ganciclovir**. It has excellent oral bioavailability and is considered the **first-line treatment** for both the induction and maintenance phases of CMV retinitis. Once ingested, it is rapidly converted to ganciclovir, which inhibits viral DNA polymerase. Its oral administration makes it superior to intravenous ganciclovir for long-term management, providing comparable efficacy with less procedural morbidity. **Why the other options are incorrect:** * **Amantadine:** An anti-influenza agent that inhibits the M2 ion channel. It is used for Influenza A and as an adjunct in Parkinson’s disease, but has no activity against CMV. * **Fludarabine:** A purine analog used as a chemotherapy agent (antimetabolite) primarily for Chronic Lymphocytic Leukemia (CLL). It is not an antiviral. * **Oseltamivir:** A neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. It does not inhibit DNA viruses like CMV. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Valganciclovir (Oral) or Ganciclovir (IV). * **Alternative for Resistant CMV:** **Foscarnet** (pyrophosphate analog) or **Cidofovir**. * **Major Side Effect:** Ganciclovir/Valganciclovir causes **bone marrow suppression** (neutropenia). * **Drug Interaction:** Avoid co-administration of Ganciclovir with **Zidovudine (AZT)** due to additive myelosuppression. * **CMV Retinitis Appearance:** Classically described as "Pizza-pie" or "Crushed cheese and tomato" fundus.
Explanation: **Explanation:** **Aminoglycosides**, such as Gentamicin, are notorious for causing ototoxicity, which can manifest as either vestibular or cochlear damage. **Why Option A is correct:** The primary mechanism of gentamicin-induced ototoxicity is **direct hair cell toxicity**. Aminoglycosides enter the hair cells of the inner ear through mechanosensitive ion channels. Once inside, they trigger the formation of **Reactive Oxygen Species (ROS)**. These free radicals initiate a pro-apoptotic signaling pathway, leading to the permanent destruction of sensory hair cells in the organ of Corti (cochlear) and the maculae/cristae (vestibular). **Why the other options are incorrect:** * **Option B:** While some drugs (like Digitalis) inhibit Na+/K+ ATPase, this is not the primary mechanism for aminoglycoside ototoxicity. * **Option C:** Aminoglycoside toxicity is **cumulative**. The drugs have a long half-life in the inner ear fluids (perilymph and endolymph) compared to plasma. Repeated dosing leads to progressive accumulation, increasing the risk of damage. * **Option D:** Aminoglycosides can actually *block* voltage-gated calcium channels at the neuromuscular junction (leading to neuromuscular blockade), but this is not the mechanism behind their ototoxicity. **NEET-PG High-Yield Pearls:** * **Order of damage:** Aminoglycosides typically affect **high-frequency hearing** first. * **Specific toxicities:** **Gentamicin and Streptomycin** are primarily vestibulotoxic (vertigo, ataxia); **Amikacin and Neomycin** are primarily cochleotoxic (hearing loss). * **Genetic Predisposition:** A mutation in the mitochondrial **12S rRNA gene (A1555G)** makes individuals highly susceptible to aminoglycoside-induced deafness. * **Drug Interaction:** Risk increases significantly when co-administered with **Loop Diuretics** (e.g., Furosemide).
Explanation: **Explanation:** **1. Why Cyclosporine is the correct answer:** Cyclosporine is an **immunosuppressant** that acts as a calcineurin inhibitor. It is primarily used to prevent organ transplant rejection and treat autoimmune conditions (e.g., rheumatoid arthritis, psoriasis). It has **no anti-protozoal activity** and is not used to treat Leishmaniasis. In fact, because it suppresses T-cell immunity, it could potentially worsen an opportunistic infection like Leishmaniasis. **2. Why the other options are incorrect:** * **Ketoconazole (Option B):** This oral antifungal inhibits ergosterol synthesis in the *Leishmania* cell membrane. It is an alternative agent used specifically for **Cutaneous Leishmaniasis**. * **Pentamidine (Option C):** This is a second-line agent for **Visceral Leishmaniasis (Kala-azar)**. It interferes with the parasite's DNA synthesis and mitochondrial function. It is often used when primary treatments fail or are contraindicated. * **Amphotericin B (Option D):** This is currently the **drug of choice** for Visceral Leishmaniasis (especially the Liposomal formulation). It binds to ergosterol in the parasite membrane, creating pores that lead to cell death. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Liposomal Amphotericin B is the preferred treatment for Kala-azar due to high efficacy and lower toxicity compared to conventional forms. * **Miltefosine:** This is the **only oral drug** approved for the treatment of Visceral Leishmaniasis. * **Sodium Stibogluconate (Antimonials):** Historically the first-line treatment, but now limited by significant resistance (especially in Bihar, India) and cardiotoxicity (QT prolongation). * **Paromomycin:** An aminoglycoside antibiotic that is also effective against *Leishmania* when given intramuscularly.
Explanation: ### Explanation **Correct Option: C. Ciprofloxacin** Ciprofloxacin belongs to the **Fluoroquinolone** class of antibiotics. The primary reason it is generally contraindicated in children (under 18 years) is its potential to cause **arthropathy** (cartilage damage). Experimental studies in juvenile animals have demonstrated that fluoroquinolones can cause permanent damage to the weight-bearing joints by inducing erosions in the articular cartilage. While clinical use in children is sometimes necessary for specific conditions (e.g., cystic fibrosis or complicated UTIs), it remains a high-yield contraindication for exams due to this risk of growth plate interference. **Analysis of Incorrect Options:** * **A. Cotrimoxazole:** This drug is primarily avoided in neonates because it competes with bilirubin for albumin binding sites, potentially leading to **kernicterus**. It does not affect cartilage. * **B. Penicillin:** These are among the safest antibiotics in the pediatric population. Their primary adverse effect is hypersensitivity (Type I IgE-mediated reactions), not musculoskeletal toxicity. * **C. Metronidazole:** Used for anaerobic infections and protozoal diseases, its main side effects include a metallic taste, disulfiram-like reaction with alcohol, and peripheral neuropathy with prolonged use. It has no known effect on cartilage. **Clinical Pearls for NEET-PG:** * **Fluoroquinolones & Tendons:** In adults, fluoroquinolones are associated with an increased risk of **tendonitis and Achilles tendon rupture**, especially in the elderly or those on corticosteroids. * **Mechanism of Action:** They inhibit **DNA Gyrase** (Gram-negative) and **Topoisomerase IV** (Gram-positive), preventing DNA supercoiling. * **Other Pediatric Contraindications:** Remember **Tetracyclines** are avoided in children <8 years due to permanent **tooth discoloration** and bone growth retardation.
Explanation: Fosfomycin is a unique bactericidal antibiotic that inhibits the first step of bacterial cell wall synthesis by inactivating the enzyme Enolpyruvate transferase (MurA). This prevents the formation of UDP-N-acetylmuramic acid, a precursor of peptidoglycan. 1. Why 3 g is correct: For the treatment of uncomplicated urinary tract infections (UTIs), specifically acute cystitis in women caused by susceptible strains of E. coli or Enterococcus faecalis, the standard FDA-approved and clinical guideline dosage is a single 3-gram oral dose. It is administered as granules dissolved in water. The drug achieves very high concentrations in the urine (up to 2000–4000 µg/mL) which remain above the MIC for most uropathogens for 24–48 hours, justifying the single-dose regimen. 2. Why other options are incorrect: 6 g (Option A): This is double the standard dose for uncomplicated UTI and is not a standard single-dose regimen. 6 mg/kg and 3 mg/kg (Options B & D): Fosfomycin dosing for UTIs is fixed, not weight-based. Weight-based dosing (mg/kg) is typically reserved for intravenous fosfomycin used in systemic or multidrug-resistant infections, but even then, the doses are significantly higher (e.g., 100–400 mg/kg/day). High-Yield Clinical Pearls for NEET-PG: Mechanism of Action: Inhibits MurA enzyme (Cell wall synthesis inhibitor). Spectrum: Broad-spectrum (Gram-positive and Gram-negative); notably effective against VRE (Vancomycin-Resistant Enterococci) and ESBL-producing organisms. Pregnancy: It is considered safe (Category B) and is often used for asymptomatic bacteriuria in pregnancy. Synergy: Often shows synergy when combined with Beta-lactams or Aminoglycosides.
Explanation: **Explanation:** The correct answer is **C** because **Benzathine penicillin** is contraindicated for the treatment of **neurosyphilis**. While it is the drug of choice for primary, secondary, and latent syphilis, it does not achieve therapeutic concentrations in the cerebrospinal fluid (CSF). For neurosyphilis, the standard of care is **Aqueous Crystalline Penicillin G** (administered IV) or Procaine Penicillin (IM) with Probenecid to ensure adequate CNS penetration. **Analysis of other options:** * **Option A:** Penicillin V (Phenoxymethylpenicillin) is indeed **acid-stable**, allowing it to resist gastric degradation and be administered orally, unlike Penicillin G. * **Option B:** **Probenecid** inhibits the organic anion transporter (OAT) in the renal tubules. This blocks the active tubular secretion of penicillins, thereby increasing their plasma concentration and **prolonging their duration of action**. * **Option D:** Penicillin V has a narrow spectrum, acting primarily against **Gram-positive** cocci (e.g., *Streptococcus pyogenes*) and some anaerobes. It is less potent than Penicillin G against Gram-negative bacteria. **High-Yield Clinical Pearls for NEET-PG:** * **Jarisch-Herxheimer Reaction:** A common systemic reaction (fever, chills) following the first dose of penicillin in syphilis patients due to the release of endotoxins from dying spirochetes. * **Drug of Choice:** Benzathine Penicillin is the gold standard for **Rheumatic fever prophylaxis**. * **Excretion:** Almost all penicillins are excreted renally; **Nafcillin** and **Oxacillin** are notable exceptions as they are primarily excreted via bile.
Explanation: **Explanation:** **Terbinafine hydrochloride** is a potent **antifungal** agent belonging to the **Allylamine** class. It is the drug of choice for dermatophytoses (fungal infections of the skin, hair, and nails). **Why Option B is Correct:** Terbinafine works by inhibiting the enzyme **Squalene Epoxidase**. This inhibition leads to two lethal effects on the fungus: 1. **Ergosterol Deficiency:** It prevents the conversion of squalene to lanosterol, depleting ergosterol, an essential component of the fungal cell membrane. 2. **Squalene Toxicity:** It causes an intracellular accumulation of squalene, which is toxic to fungal cells, resulting in a **fungicidal** action. **Why Other Options are Incorrect:** * **Option A (Antibacterial):** Antibacterials target bacterial structures like the peptidoglycan cell wall or 70S ribosomes. Terbinafine has no activity against bacteria. * **Option C (Antiviral):** Antivirals inhibit viral replication (e.g., DNA polymerase or protease inhibitors). Terbinafine does not interfere with viral machinery. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Highly effective against **Dermatophytes** (Tinea infections) and *Onychomycosis* (nail infections). It is less effective against *Candida*. * **Pharmacokinetics:** It is highly **lipophilic** and **keratophilic**, meaning it accumulates in high concentrations in skin, nails, and adipose tissue. * **Route:** Available both topically and orally. * **Side Effects:** While generally well-tolerated, oral use can rarely cause **hepatotoxicity** and taste disturbances (dysgeusia). * **Comparison:** Unlike Azoles, Terbinafine does **not** inhibit the Cytochrome P450 system significantly, leading to fewer drug interactions.
Explanation: **Explanation:** **Ketoconazole** is the correct answer because it possesses a unique pharmacological profile that extends beyond its antifungal activity. At high doses, it acts as a potent inhibitor of several cytochrome P450 enzymes involved in steroid biosynthesis, most notably **11β-hydroxylase** and **17α-hydroxylase**. By blocking these enzymes, it effectively reduces the production of cortisol in the adrenal cortex, making it a first-line medical treatment for managing hypercortisolism in **Cushing’s syndrome** (especially when surgery is not an option or has failed). **Analysis of Incorrect Options:** * **Fluconazole:** While it is a widely used triazole for systemic candidiasis and cryptococcal meningitis, it is much more selective for fungal CYP450 enzymes and does not significantly inhibit human steroidogenesis. * **Itraconazole:** This is the drug of choice for histoplasmosis and blastomycosis. Like fluconazole, it lacks the potent inhibitory effect on adrenal steroid enzymes required to treat Cushing's. * **Miconazole:** This is primarily used as a topical agent for superficial fungal infections (like tinea or candidiasis) and does not have a systemic role in treating endocrine disorders. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action (Antifungal):** Inhibits 14α-demethylase, preventing the conversion of lanosterol to ergosterol. * **Adverse Effects:** Due to its non-selective inhibition of mammalian steroid enzymes, it can cause **gynecomastia**, decreased libido, and impotence in men (by inhibiting testosterone synthesis). * **Hepatotoxicity:** It carries a "Black Box Warning" for potentially fatal liver injury. * **Absorption:** It requires an **acidic gastric pH** for absorption; therefore, its efficacy is reduced if taken with antacids, H2 blockers, or PPIs.
Explanation: **Explanation:** **Palivizumab** is a humanized monoclonal antibody (IgG1) directed against the **F (fusion) protein** of the **Respiratory Syncytial Virus (RSV)**. By binding to this protein, it prevents the virus from fusing with the host cell membrane, thereby inhibiting viral entry and replication. * **Why Option D is correct:** Palivizumab is specifically FDA-approved for the **prophylaxis** of serious lower respiratory tract disease caused by RSV in high-risk pediatric patients (e.g., infants with bronchopulmonary dysplasia, history of premature birth, or hemodynamically significant congenital heart disease). It is administered intramuscularly once a month during the RSV season. **Analysis of Incorrect Options:** * **A. Coxsackievirus:** This is an enterovirus (Picornaviridae) causing conditions like Hand-Foot-and-Mouth disease or myocarditis. There is no approved monoclonal antibody for its prevention; management is primarily supportive. * **B. Avian Influenza:** Treatment and prophylaxis for influenza involve neuraminidase inhibitors (Oseltamivir) or cap-dependent endonuclease inhibitors (Baloxavir). Palivizumab has no activity against the influenza virus. * **C. Parainfluenza:** While it causes croup (laryngotracheobronchitis) in children, there is currently no licensed vaccine or monoclonal antibody available for Parainfluenza. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** Targets the **F-protein** (Fusion protein) of RSV. 2. **Indication:** Prophylaxis only, **not** for the treatment of active RSV infection. 3. **Route:** Intramuscular (IM). 4. **Nomenclature:** The suffix **"-zumab"** indicates it is a **humanized** monoclonal antibody (approx. 95% human, 5% mouse). 5. **Alternative:** **Nirsevimab** is a newer, long-acting monoclonal antibody recently approved for RSV prophylaxis in all infants.
Explanation: ### Explanation The correct answer is **Cloxacillin**. **1. Why Cloxacillin is correct:** Cloxacillin belongs to the **Penicillinase-resistant penicillins** (also known as Antistaphylococcal penicillins), which include Nafcillin, Oxacillin, and Dicloxacillin. These drugs possess a bulky side chain that sterically hinders the access of the bacterial enzyme **beta-lactamase (penicillinase)** to the beta-lactam ring. This makes them the drugs of choice for treating infections caused by penicillinase-producing *Staphylococcus aureus* (MSSA). **2. Why the other options are incorrect:** * **Penicillin G/V:** These are "Natural Penicillins." They are highly susceptible to degradation by beta-lactamases produced by most strains of Staphylococci and are now primarily used for non-beta-lactamase producing organisms like *Streptococcus pyogenes*. * **Ampicillin:** This is an "Extended-spectrum penicillin." While it has better gram-negative coverage, it is **not** resistant to beta-lactamase. It is often combined with a beta-lactamase inhibitor (e.g., Sulbactam) to restore its activity. * **Carbenicillin:** This is an "Antipseudomonal penicillin." Like ampicillin, it is susceptible to destruction by staphylococcal beta-lactamase. **3. NEET-PG High-Yield Pearls:** * **MRSA Mechanism:** Resistance in Methicillin-resistant *S. aureus* (MRSA) is **not** due to beta-lactamase, but due to an altered target site (**PBP-2a**), encoded by the **mecA gene**. Therefore, Cloxacillin is ineffective against MRSA. * **Excretion:** Nafcillin is primarily excreted via **bile**, making it safe in patients with renal failure (no dose adjustment needed). * **Acid Stability:** Cloxacillin and Dicloxacillin are acid-stable and can be given orally, whereas Methicillin is acid-labile (and no longer used clinically due to interstitial nephritis).
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free